Publikationen – Webseite OIs

Multiple Myeloma

Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to PI, IMiD and anti-CD-38 from a German registry
Goldschmidt H., Merz M., Hari P., Agha M., Diels J., Ghilotti F., Haefliger B., C Sakabedoyan C., Bacon T., Schecter J., Jackson C., Olyslager Y., Carrasco-Alfonso MJ., Nesheiwat T., Kellermann L., Jagannath S., Poster EHA 2021 --> PDF
Baseline characteristics and survival outcomes of patients with tri exposed multiple myeloma in a German registry
Haefliger B., Diels, J., Ghilotti F., Sliwka H., Potamianou A., Bacon T., Kellermann L., Poster EHA 2021 --> PDF
Evolving Treatment Trends in Relapsed/Refractory Multiple Myeloma in Europe from 2016 to 2018:Analysis of a Multi-National Survey
Maximilian Merz, Isabelle Vande Broek, Manuel Pérez, Brigitte Kolb, Argiris Symeonidis, Emmanouil Nikolousis, Athanasios Zomas, Francisco Gonzalez, Lenka Kellermann, Hartmut Goldschmidt, Poster ASH 2019 --> PDF
Treatment Patterns in Patients with Refractory/Relapsed Multiple Myeloma in Germany Between 2016 and 2018
Maximilian Merz, Vishal Patel, Lucie Kutikova, Andrea Lebioda, Martina Schoehl, Lenka Kellerman, Hartmut Goldschmidt, Poster ASH 2019 --> PDF
Diagnostic and therapeutic approaches to multiple myeloma patients: ‘Real-world’ data from representative multicentre treatment surveys in Germany between 2008 and 2011
THOMAS M. MOEHLER, MAXIMILIAN MERZ, LENKA KELLERMANN, HARTMUT GOLDSCHMIDT and WOLFGANG KNAUF, Oncology Letters Vol 12 No 6, p.5043-5051, 2016 --> PDF
Diagnosis and treatment of multiple myeloma in Germany – Analysis of a nationwide, multi-institutional survey
Maximilian Merz, Lenka Kellermann, Wolfram Poenisch, Hans-Joachim Tischler, Joern Kohnke, Wolfgang Knauf and Hartmut Goldschmidt, Poster DGH0 2016 --> PDF
Comparative Effectiveness of Pomalidomide Plus Low-Dose Dexamethasone (POM+LoDEX) in Relapsed and Refractory Multiple Myeloma: Use of Real-World Data in the Absence of Head-to-Head Studies
Hartmut Goldschmidt, Rebecca Harvey, Dawn Lee, Sujith Dhanasiri, Pellegrino Musto, Sergio Storti, Lucia Pantani, Lenka Kellermann, Brigitte Kolb, Gordon Cook --> PDF
Treatment of Multiple Myeloma in Germany
An update of a representative multicentre health care survey 2004‐2011 Knauf Wolfgang, Kellermann Lenka, David Bórquez, Brendel Kurt, Buschmann Dirk, Ehlers Thomas, Görg, Christian, Poenisch Wolfram, Goldschmidt Hartmut --> PDF
How to Treat Multiple Myeloma – A Representative Mulicentre Treatment Survey
Wolfgang Knauf, Lenka Kellermann, Wolfgang Poenisch, Hermann Einsele, Christian Straka, Claas Frohn, Hartmut Goldschmidt. --> PDF
Zeitschrift Onkologie Vol. 33, No.11, 2010, S.604-610 --> Link
Anwendung neuer Therapien zur Behandlung des Multiplem Myelom
Ergebnisse einer repräsentativen multizentrischen Erhebung 2006 R. Angermund, W.Knauf, M.Freund, M.Nowrusian, H. Einsele, H. Goldschmidt, W. Berdel, W. Poenisch, C. Straka, L. Kellermann, H. Pliskat --> PDF
Treatment Situation for Newly Diagnosed Multiple Myeloma (MM) Patients in Germany
Mathias R.F. Freund, W. Knauf, H. Goldschmidt, H. Einsele, M. R. Nowrousian, W. E. Berdel, W. Poenisch, C. Straka, L. Kellermann, S. Bammer, R. Angermund. ASH 47th annual meeting Atlanta 2005, Publication Only, Abstract 5158 --> PDF
Role of Bortezomib in the Treatment of Multiple Myeloma – First Results from a Representative Multicentre Treatment Survey in Germany (GER)
Ralf Angermund, W. Knauf, M. Freund, M. R. Nowrousian, H. Einsele, H. Goldschmidt, W. E. Berdel, W. Poenisch, C. Straka, L. Kellermann, S. Bammer. ASH 47th annual meeting Atlanta 2005, Publication Only, Abstract 5156 --> PDF

Non Hodgkin Lymphome

Treatment of Chronic Lymphocytic Leukemia in Germany
Results of a representative population‐based survey in 2011 Zoellner A.‐K., Höhler T., Fries S., Böhme A.A., Kiewe P., Kellermann L., Dreyling M. --> PDF
Indolente Non Hodgkin Lymphome – Trends in der Diagnose und in der Therapie in Deutschland (2006-2009)
Schmidt C., Fingerle-Rowson G., Boehme, Brendel K., Fischer R., Gonnermann M., Höhler T., Kegel T., Kellermann L., Nusch A., Pönisch W., Woitinas F., Wendtner C.-M., Dreyling M. --> PDF
Behandlung indolenter Lymphome in Deutschland
Ergebnisse einer repräsentativen multizentrischen Erhebung 2006 M. Dreyling, S. Fetscher, Ch. Görg, M. Kornek, M. Nusch, M. Kornacker, R. Angermund, H. Pliskat, L. Kellermann, T. Kegel --> PDF

Myelodisplactic Syndrome

Real-world data in a German healthcare survey demonstrate a high medical need of patients with lower risk MDS and ringsideroblasts.
Kaivers J., Garz A.-K., Kellermann L., Frank M., Ludäscher M., Schackert N., Gattermann N., Germing U., Poster DGHO 2020 --> PDF
Erste Ergebnisse einer multizentrischen retrospektiven Analyse zur Diagnose und Behandlung von MDS-Patienten in Deutschland
N. Gattermann1, A. Kündgen1, L. Kellermann2, M. Zeffel3, N. Lang3, U. Germing1 1 Heinrich-Heine-Universität Düsseldorf, 2 Oncology Information Service Freiburg, 3 Celgene GmbH München. --> PDF
Die Ergebnisse wurden auf der DGHO Jahrestagung 2010 in Berlin als Poster vorgestellt. --> Link

Gastric Cancer

Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany
Kirsten Merx, Manuel Barreto Miranda, Lenka Kellermann, Ulrich Mahlknecht, Oliver Lange, Michael Gonnermann, and Ralf-Dieter Hofheinz --> PDF
Gastroenterology Research and Practice, Volume 2016, Article ID 1028505, 7 pages --> Link
Metastatic Esophagogastric Adenocarcinoma: Trends in First-Line Treatment and Predictive Factors for the Implementation of HER2 Testing in Clinical Practice During the First Year after Trastuzumab Market Approval
Deniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, Ali-Nuri Hünerlitürkoglu,,Michael Gonnermann, Thomas Kegel, Harald Scheiber, Wolf-Oliver Jordan, Iris Burkholder, Lenka Kellermann, Ralf-Dieter Hofheinz.
Journal of Cancer Res Clin Oncol. 2013 Feb;139(2):337-45 --> Link
Population-Based Patterns of Care in the First-Line Treatment of Patients with Advanced Esophagogastric Adenocarcinoma in Germany
Populations-bezogene Behandlungsrealität in der 1st line Therapie von Patienten mit fortgeschrittenem Adenokarzinom des Ösophagus oder Magens in Deutschland R.-D. Hofheinz, S.-E. Al-Batran, K. Ridwelski, C. Görg, K. Wehle, M. Birth, S. Fetscher, H. Scheiber, N. Lukan, F. Lordick --> PDF
Der Artikel erschien in der Zeitschrift Onkologie Vol. 33, No.10, 2010, S. 512-518 --> Link
Population-Based Patterns of Care in the Treatment of 678 Patients with Gastric Cancer
Hofheinz, R; Al-Batran S.; Kellermann, L.; Arnold, D. in: Onkologie 2006;29 (suppl3), S. 11-12 --> PDF

Colorectal Cancer

Did the uptake of new treatment options change the treatment strategy in patients with colorectal cancer and primary non-resectable metastases?
The results of large population-based survey in Germany 2005-2007 Lenka Kellermann, Dirk Arnold, Salah-Eddin Al-Batran, Hans-Joachim Schmoll --> PDF
Defizite in der Behandlung von Patienten mit kolorektalem Karzinom in Deutschland
Axel Grothey, Lenka Kellermann, Hans - Joachim Schmoll, in: Medizinische Klinik, Vol.97, Nr. 5 Mai 2002, S. 270- 277 --> PDF

Prostate Cancer

SURECAP: Survey and Evaluation of Castration Resistant Prostate Cancer (CRPC) in Germany
Axel S. Merseburger, Lenka Kellermann, Andreas Janitzky, Martin Hatzinger, Susan Feyerabend, Christiana Lütter, Katrin Krützfeldt, Marina Akkermann, Natasha Schuier Poster presented at the 8th European Multidisciplinary Meeting on Urological Cancers, Milan, Italy 2016 --> PDF

Ovarian Cancer

Die Therapie des fortgeschrittenen Ovarialkarzinoms in Deutschland
A. du Bois, J. Pfisterer, L. Kellermann, in: Der Onkologe, Vol.8, Part. 11 2002, S. 2101-1215 --> PDF

Lung Cancer

Disparities in Access to EGFR‐Mutation Testing in Patients with Advanced NSCLC in Germany 2011
Lenka Kellermann, Dieter Ukena The results were presented in a poster at the ISPOR Annual European Congress 2012. --> PDF